Ekaterina Allen

FDA investigator

Appears on 6 documents from 2021 to 2025, most often at sites in Italy. Most often cites control of microbiological contamination (21 CFR 211.113).

6
Documents on file
7.8
Observations per 483
2021
First seen
2025
Most recent

What they cite most

From 39 observations

Activity by year

2021: 2, 2024: 2, 2025: 2

Where

Italy 2 · Massachusetts 2 · Iceland 1 · Maryland 1

Is Ekaterina Allen coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

6 documents, newest first
FirmOpen
483 Alvotech HfJul 4, 2025 · Reykjavik, Iceland
483 Thermo Fisher ScientificFeb 18, 2025 · Ferentino, Italy
483 Catalent Anagni S.R.L.Jul 16, 2024 · ANAGNI, Italy
483 AstraZeneca Pharmaceuticals LPMay 31, 2024 · Gaithersburg, Maryland
483 Wyeth BioPharma Division of Wyeth Pharmaceuticals LLCJul 23, 2021 · Andover, Massachusetts
EIR Wyeth BioPharma Division of Wyeth Pharmaceuticals LLCJul 23, 2021 · Andover, Massachusetts

About this profile

What does Ekaterina Allen inspect?

Ekaterina Allen appears on 6 documents on file covering 5 sites, most often in Italy.

What do they cite most often?

21 CFR 211.113 (control of microbiological contamination), followed by 21 CFR 211.42 and 21 CFR 211.192.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Ekaterina Allen is dated Jul 4, 2025.